Regulation  
 
Home
About Us
Biotech
Careers
Executives
FDA
Financial
HIPAA
Managed Care
Medicare/Medicaid
Medical Research
Partnerships
Pharmaceuticals
Regulation
Stock Selection
Contact Us
  Hot News
 

 

 

 


  Info Box

 

 

 

 

 


 
  • DaVita Clinical Research Completes Record Number of Renal Trials in 2007

  • Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies

  • Bill Moyers' Journal to Feature CA Nurses Assoc/National Nurses Organizing Co...

  • ALL: More Dead Babies Found in MI Dumpsters

  • Medicare Fee Cuts Could Devastate Rehabilitation Services, Physical Therapist...

  • FDA OKs Abilify for secondary use against bipolar disorder

  • FDA Sends Letter to Shire Over Fosrenol Promotional Materials

  • GAO Report: PRESCRIPTION DRUGS - Trends in FDA's Oversight of Direct-to-Consu...

  • Lawmakers, Industry Representatives, Officials Discuss Medicare Competitive B...

  • Medicare to tighten sales practices on Advantage plans

  • US FDA Approves ABILIFY for Add-On Treatment to Lithium or Valproate in the A...

  • Drug companies defend TV advertisements before Congress

  • Closing Glance: Pharmaceuticals gain with broader market

  • Drugmakers need to rein in ads, hearing told

  • Dramatic Las Vegas Vote by RNs for Change

  • AHIP Statement on CMS Proposed Medicare Marketing Regulations

  • Buy-Rated Pozen Worth the Risks

  • FDA clears Covidien RFID contrast system

  • AMA Urges Congress To Save Specialty Hospitals For Patients

  • Senate Finance Committee Holds 1st In Series Of Congressional Hearings On US ...

  •   Info Box

     

     

     

     


     

     

     

     

     

     
    Copyright © 2006. BioHQ.com. All rights reserved.